Cedars-Sinai investigators have discovered that large oncosomes—fluid-filled sacs released into the bloodstream by aggressive ...

Regeneron Pharmaceuticals, Inc. REGN obtained FDA approval for linvoseltamab-gcpt for the treatment of relapsed or refractory ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Bruna was subsequently prescribed antidepressants, but despite her condition steadily worsening, her concerns were repeatedly ...

A student has shared her experience of being repeatedly dismissed by doctors, despite losing 10 kilos in just two months and ...

Large cell neuroendocrine carcinoma of the lung is a rare and aggressive form of lung cancer, exhibiting characteristics of both small-cell and non-small-cell lung cancers, according to the National ...

Small-cell lung cancer is when abnormal cells in your lung grow fast and uncontrollably. It’s an aggressive form of cancer that often starts in your airways and then spreads, or metastasizes, to ...

Neuroendocrine cancer can start in any part of the body. Doctors often name them after the part of the body where they develop. They call this the primary site. They also name some NETs after the type ...

Stomach NETs Colorectal NETs Paragangliomas and pheochromocitomas Renal NETs Other Types of Neuroendocrine Cancer We are experts in treating aggressive types of neuroendocrine cancers, often referred ...

Large cell neuroendocrine carcinoma (LCNEC) Large cell neuroendocrine carcinomas are grade 3 cancers. They tend to grow quickly and are more likely to spread. The cancer cells look very abnormal.

In a recent study published in Cancer Cell, researchers performed a molecular analysis of neuroendocrine neoplasm (NEN) patient-derived tumor organoids (PDTOs) and their parental neoplasms. Study ...

We establish patient-derived tumor organoids (PDTOs) from pulmonary NETs and derive PDTOs from an understudied subtype of NEC, large cell neuroendocrine carcinoma (LCNEC), arising from multiple ...